β-Gemcitabine 13C,15N2 Hydrochloride
| Product Name | β-Gemcitabine 13C,15N2 Hydrochloride |
|---|---|
| Alternate Names | Gemcitabine Stable Isotopes, Stable Isotopes of Gemcitabine |
| CAT No. | CS-O-14759 |
| CAS No. | 1233921-74-8 (Freebase) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 302.64 g/mol |
| Mol. For. | C₈¹³CH₁₂ClF₂N¹⁵N₂O₄ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Gemcitabine |
| Purity | >98% |
| Therapeutic | Immunosuppressants |
| Smileys | FC1([C@@H]([15N](C=CC(N)=[15N]2)[13C]2=O)O[C@H](CO)[C@H]1O)F.Cl |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
β-Gemcitabine 13C,15N2 Hydrochloride is a modified version of the drug Gemcitabine, which is commonly used to treat various types of cancer. The addition of carbon-13 and nitrogen-15 isotopes to the compound allows for more precise tracking and analysis of its distribution and metabolism within the body. This enables researchers to gain a better understanding of how the drug is working, and potentially identify ways to optimize its effectiveness.
Chemically, β-Gemcitabine 13C,15N2 Hydrochloride is a nucleoside analogue, meaning it mimics the structure of the nucleosides that make up DNA. When the drug is taken up by cancer cells, it is incorporated into their DNA, disrupting their ability to divide and ultimately leading to cell death. This mechanism of action makes it particularly effective against rapidly dividing cancer cells.
The drug is typically administered intravenously, and the dose and frequency of treatment will depend on the type and stage of cancer being treated, as well as the patient's overall health. Common side effects of β-Gemcitabine 13C,15N2 Hydrochloride include nausea, vomiting, fatigue, and decreased white blood cell count. As with all medications, it is important to follow the prescribed dosing instructions and to consult with a healthcare professional if any concerning side effects arise.
Get an Instant Quote
Related Compounds
Gemcitabine triphosphate 13C,15N2 | Gemcitabine Triphosphate-13C-15N2 Tri(triethylamine) Salt | Gemcitabine 13C,15N2 Hydrochloride | Gemcitabine Diphosphate-13C-15N2 Tri(triethylamine) Salt | Gemcitabine Monophosphate-13C,15N2 |